Krishna Institute of Medical Sciences Limited has disclosed that its subsidiary, Spanv Medisearch Lifesciences Private Limited, has received a GST demand order of about Rs 12.42 crore from the Office of the Deputy Commissioner of State Tax (GST), Nagpur, for FY 2021-22, alleging non-payment of GST on medicines supplied to in-patients.
Krishna Institute of Medical Sciences Limited (KIMS) has informed the exchanges that its subsidiary, Spanv Medisearch Lifesciences Private Limited, has received a demand order from the Office of the Deputy Commissioner of State Tax (GST), Nagpur. The order, dated 31 December 2025, pertains to alleged tax dues for FY 2021-22.
The demand has been raised under section 73 read with rule 100(1), 100(2), 100(3) and 142(5) of the GST framework, aggregating to Rs 12,42,46,602.68, including interest and penalty, with a direction to settle the dues by 30 March 2026. The basis of the order is the alleged non-payment of GST on medicines consumed for in-patients.
KIMS has stated that the company and its subsidiary are currently examining the order in consultation with legal and tax advisors and are exploring all legal options, including filing an appeal before the appropriate appellate authority. The company has not quantified any immediate operational impact but has indicated that it will take necessary steps as per applicable laws.
Key Highlights
-
Order issued by the Office of the Deputy Commissioner of State Tax (GST), Nagpur, for FY 2021-22.
-
Total demand of Rs 12,42,46,602.68, including interest and penalty, to be paid on or before 30 March 2026.
-
Allegation relates to non-payment of GST on medicines consumed for in-patients.
-
Order passed under section 73 read with rule 100(1), 100(2), 100(3) and 142(5) of GST provisions.
-
Company is reviewing the matter and considering an appeal before the relevant appellate authority.
Sources: Stock exchange disclosure by Krishna Institute of Medical Sciences Limited (NSE corporate filing).